Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Masahito Nagashima
Efficacy and Safety of Monotherapy by Pegvisomant, a Growth Hormone Receptor Antagonist, in Japanese Patients With Acromegaly
Endocrine Journal
Endocrinology
Metabolism
Diabetes
Related publications
Clinical Pharmacodynamic Effects of the Growth Hormone Receptor Antagonist Pegvisomant: Implications for Cancer Therapy
Clinical Cancer Research
Cancer Research
Oncology
Glucose Homeostasis and Safety in Patients With Acromegaly Converted From Long-Acting Octreotide to Pegvisomant
Journal of Clinical Endocrinology and Metabolism
Biochemistry
Endocrinology
Clinical Biochemistry
Medicine
Metabolism
Diabetes
Efficacy and Safety of Growth Hormone Replacement Therapy in Japanese Adults With Growth Hormone Deficiency: A Post-Marketing Observational Study
Endocrine Journal
Endocrinology
Metabolism
Diabetes
Long-Term Treatment With Pegvisomant: Observations From 2090 Acromegaly Patients in ACROSTUDY.
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Clinical Efficacy of Tolterodine for Patients With Overactive Bladder After Insufficient Efficacy by Monotherapy With .Alpha.1-Adrenoceptor Antagonist
Japanese Journal of Urology
Urology
Efficacy and Safety of Tofacitinib as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis: A 12-Week, Randomized, Phase 2 Study
Modern Rheumatology
Medicine
Rheumatology
What Is the Efficacy of Switching to Weekly Pegvisomant in Acromegaly Patients Well Controlled on Combination Therapy?
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Romiplostim Monotherapy in Thrombocytopenic Patients With Myelodysplastic Syndromes: Long-Term Safety and Efficacy
British Journal of Haematology
Hematology
Combined Treatment With Octreotide LAR and Pegvisomant in Patients With Gigantism - Acromegaly: Clinical Evaluation and Genetic Screening
Endocrine Abstracts
